| Melvin Pelletier Payne Iii, MD | |
|
2996 Kate Bond Rd, Suite 309, Bartlett, TN 38133-4030 | |
| (901) 726-1056 | |
| (901) 726-5867 |
| Full Name | Melvin Pelletier Payne Iii |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 36 Years |
| Location | 2996 Kate Bond Rd, Bartlett, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033229216 | NPI | - | NPPES |
| 3816845 | Medicaid | TN | |
| P00135739 | Other | TN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 29662 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Bartlett Medical Center | Bartlett, TN | Hospital |
| St Francis Hospital | Memphis, TN | Hospital |
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Francis Physician Network, Llc | 2365701943 | 66 |
News Archive
In keeping with society's urgent need for more efficient and effective health care, Priority Health and Cancer and Hematology Centers of West Michigan (CHCWM) have joined forces to explore an innovative oncology patient-centered medical home.
Post-traumatic stress disorder, or PTSD, affects many people who are exposed to extreme situations, such as torture. Recent research suggests that chronic pain may make it more difficult to treat trauma
In human relationships, a certain "spark" often governs whether we prefer one person more than another, and critical first impressions can occur within seconds. A team lead by Johns Hopkins researchers has found that cell-to-cell "friendships" operate in much the same way and that dysfunctional bonding is linked to the spread of cancer.
"A United Nations nutrition report [.pdf] released [Monday] shows that progress has been made in recent years in addressing stunting in children, and calls for increased efforts to accelerate a response to a condition that affects some 165 million children across the world," the U.N. News Centre reports.
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
› Verified 7 days ago
| Entity Name | Saint Francis Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295258002 PECOS PAC ID: 2365701943 Enrollment ID: O20180129001351 |
News Archive
In keeping with society's urgent need for more efficient and effective health care, Priority Health and Cancer and Hematology Centers of West Michigan (CHCWM) have joined forces to explore an innovative oncology patient-centered medical home.
Post-traumatic stress disorder, or PTSD, affects many people who are exposed to extreme situations, such as torture. Recent research suggests that chronic pain may make it more difficult to treat trauma
In human relationships, a certain "spark" often governs whether we prefer one person more than another, and critical first impressions can occur within seconds. A team lead by Johns Hopkins researchers has found that cell-to-cell "friendships" operate in much the same way and that dysfunctional bonding is linked to the spread of cancer.
"A United Nations nutrition report [.pdf] released [Monday] shows that progress has been made in recent years in addressing stunting in children, and calls for increased efforts to accelerate a response to a condition that affects some 165 million children across the world," the U.N. News Centre reports.
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melvin Pelletier Payne Iii, MD 6029 Walnut Grove Rd, Suite 404, Memphis, TN 38120-2112 Ph: (901) 726-1056 | Melvin Pelletier Payne Iii, MD 2996 Kate Bond Rd, Suite 309, Bartlett, TN 38133-4030 Ph: (901) 726-1056 |
News Archive
In keeping with society's urgent need for more efficient and effective health care, Priority Health and Cancer and Hematology Centers of West Michigan (CHCWM) have joined forces to explore an innovative oncology patient-centered medical home.
Post-traumatic stress disorder, or PTSD, affects many people who are exposed to extreme situations, such as torture. Recent research suggests that chronic pain may make it more difficult to treat trauma
In human relationships, a certain "spark" often governs whether we prefer one person more than another, and critical first impressions can occur within seconds. A team lead by Johns Hopkins researchers has found that cell-to-cell "friendships" operate in much the same way and that dysfunctional bonding is linked to the spread of cancer.
"A United Nations nutrition report [.pdf] released [Monday] shows that progress has been made in recent years in addressing stunting in children, and calls for increased efforts to accelerate a response to a condition that affects some 165 million children across the world," the U.N. News Centre reports.
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
› Verified 7 days ago
David Benjamin Gibson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2996 Kate Bond Rd, Suite 309, Bartlett, TN 38133 Phone: 901-726-1056 Fax: 901-726-5867 | |
Mrs. Aimee Katharine Tutton, CST, CSFA Surgery Medicare: Not Enrolled in Medicare Practice Location: 2986 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-820-7460 | |
Crystal Adrienne Hayes, Surgery Medicare: Not Enrolled in Medicare Practice Location: 2986 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-820-7460 | |
Debra Shannon, Surgery Medicare: Not Enrolled in Medicare Practice Location: 2986 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-820-7460 | |
Dr. Michael M. Fox, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 6563 Stage Oaks Dr, Suite 100, Bartlett, TN 38134 Phone: 901-362-5252 Fax: 901-572-1264 |